Ann: Application for quotation of securities - NEU, page-9

First 9 Last

Share
Profile

Follow
Saus

996 Posts.

174

28/03/23

12:42

Post #: 66996433
Share

Originally posted by Vapor: ↑

“All loan funded shares under the plan during the year ended 31 December 2021 are subject to the following vesting conditions:
i. 40% of the Loan Funded Shares shall vest on acceptance by the US Food and Drug Administration of the filing of a New Drug Application for Trofinetide; and
ii. 40% of the Loan Funded Shares shall vest when the Company determines to progress NNZ-2591 to a Phase 2b or Phase 3 clinical trial following a positive Phase 2 clinical trial outcome, or executes a partnering transaction for NNZ-2591;
iii. 20% of the Loan Funded Shares shall vest when the Company executes a partnering transaction for trofinetide outside. North America, or submits a Marketing Authorisation Application for trofinetide in the European Union, the United Kingdom, or Japan.”

There was 3,000,000 loan funded shares in the last annual report. 1,500,000 of those were the CEO.
20% of 1,500,000 is 300,000. I’m seeing condition iii being the one met as each of the others would result in the issue of more shares.

Expand

Vapor,
Nice pick-up. maybe Neuren have submitted a Marketing Auth application to European Medicines Agency as a fillip for potential ROW partner?

NEU Price at posting: $13.09 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Hopes turn on Israel-Iran attacks barely rattling crude price | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

BBT

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

ASM

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

PH2

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $12.87		Change -0.090(0.69%)		Mkt cap ! $1.602B

Open	High	Low	Value	Volume
$12.82	$13.02	$12.70	$1.138M	88.58K

Buyers (Bids)

No.	Vol.	Price($)
6	900	$12.86

Sellers (Offers)

Price($)	Vol.	No.
$12.88	478	8

View Market Depth

No.	Vol.	Price($)
12	519	12.890
4	725	12.880
6	1449	12.870
7	1749	12.860
6	1375	12.850

Price($)	Vol.	No.
12.910	409	9
12.920	712	9
12.930	1837	9
12.940	1351	7
12.950	1309	5

Last trade - 11.19am 17/06/2025 (20 minute delay)

NEU (ASX) Chart

Ann: Application for quotation of securities - NEU, page-9

ASX Market Open: Hopes turn on Israel-Iran attacks barely rattling crude price | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Application for quotation of securities - NEU, page-9

Top Stories

ASX Market Open: Hopes turn on Israel-Iran attacks barely rattling crude price | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

'Clearly superior': Betr doesn't want to accept PointsBet picking Mixi instead

'Encouraging' signs as ASM puts cash-saving options to test at Dubbo drill site

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News